AU2001252066A1 - An improved pt(iv) antitumor agent - Google Patents

An improved pt(iv) antitumor agent

Info

Publication number
AU2001252066A1
AU2001252066A1 AU2001252066A AU5206601A AU2001252066A1 AU 2001252066 A1 AU2001252066 A1 AU 2001252066A1 AU 2001252066 A AU2001252066 A AU 2001252066A AU 5206601 A AU5206601 A AU 5206601A AU 2001252066 A1 AU2001252066 A1 AU 2001252066A1
Authority
AU
Australia
Prior art keywords
improved
antitumor agent
antitumor
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001252066A
Inventor
Christen M. Giandomenico
Ernest S. Y. Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anormed Inc
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/547,074 external-priority patent/US6518428B1/en
Application filed by Anormed Inc filed Critical Anormed Inc
Publication of AU2001252066A1 publication Critical patent/AU2001252066A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
AU2001252066A 2000-04-11 2001-04-11 An improved pt(iv) antitumor agent Abandoned AU2001252066A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/547,074 US6518428B1 (en) 1999-04-13 2000-04-11 Process for preparing amine platinum complexes
US09547074 2000-04-11
US09679952 2000-10-04
US09/679,952 US6413953B1 (en) 1999-04-13 2000-10-04 Pt(IV) antitumor agent
PCT/CA2001/000518 WO2001076569A2 (en) 2000-04-11 2001-04-11 An improved pt(iv) antitumor agent

Publications (1)

Publication Number Publication Date
AU2001252066A1 true AU2001252066A1 (en) 2001-10-23

Family

ID=27068452

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001252066A Abandoned AU2001252066A1 (en) 2000-04-11 2001-04-11 An improved pt(iv) antitumor agent

Country Status (4)

Country Link
US (1) US6413953B1 (en)
AR (1) AR029509A1 (en)
AU (1) AU2001252066A1 (en)
WO (1) WO2001076569A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6806289B1 (en) * 2000-07-14 2004-10-19 Stephen J. Lippard Coordination complexes, and methods for preparing by combinatorial methods, assaying and using the same
CA2555811A1 (en) 2004-02-18 2005-08-25 Gpc Biotech Ag Methods for treating resistant or refractory tumors
US8618082B2 (en) * 2004-03-02 2013-12-31 Wisconsin Alumni Research Foundation Lupeol anti-tumor agent and uses thereof
CZ296459B6 (en) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Peroral pharmaceutical composition for targeted transport of platinum complex into colorectal region, process for its preparation, and the composition used as a medicament
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
EP2178893A4 (en) * 2007-07-16 2012-09-19 Poniard Pharmaceuticals Inc Oral formulations for picoplatin
US20110052580A1 (en) * 2008-02-08 2011-03-03 Poniard Pharmaceuticals, Inc. Use of picoplatin and bevacizumab to treat colorectal cancer
CN101775040B (en) * 2009-12-31 2012-05-09 南京臣功制药有限公司 New method for preparing picoplatin
CN104231000A (en) * 2014-08-20 2014-12-24 山东铂源药业有限公司 Synthesis method of antitumor drug Picoplatin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105037D0 (en) * 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
AU770006B2 (en) * 1999-04-13 2004-02-12 Anormed Inc. Process for preparing amine platinum complexes

Also Published As

Publication number Publication date
WO2001076569A3 (en) 2002-06-27
WO2001076569A2 (en) 2001-10-18
US6413953B1 (en) 2002-07-02
AR029509A1 (en) 2003-07-02

Similar Documents

Publication Publication Date Title
AU2002224595A1 (en) Antitumor agents
AU2001228708A1 (en) Coin-validation arrangement
AU2001258639A1 (en) Self-service terminal
EP1160744A3 (en) Self-service terminal
AU2001247266A1 (en) Electronic plural component proportioner
AU2001274295A1 (en) Self-service terminal
AU2001252066A1 (en) An improved pt(iv) antitumor agent
AU2002246498A1 (en) Functional balanced-lethal host-vector systems
EP1151667A3 (en) Plant-activating agent
AU2001294969A1 (en) Platinum complexes as antitumor agents
AU2001278694A1 (en) Avermectin derivatives
AU2001257113A1 (en) Airbag assembly
AU2001244319A1 (en) Seat arrangement
AU2000251235A1 (en) Dual hydroturbine unit
AUPR182400A0 (en) An apparatus (ap27)
AUPR270201A0 (en) Character generation system
AU2002221099A1 (en) Combination drugs
AU2002213736A1 (en) Wc system
AU7446000A (en) Antitumor agents
AU2001272718A1 (en) Medicaments
AU2001292226A1 (en) Wide back protection for motorbikers
AU2002212905A1 (en) An air-bag arrangement
AU2002220881A1 (en) Noble gas complexes
AU1608801A (en) Diamino platinum (ii) antitumor complexes
AU2000276978A1 (en) An earpiece